Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gastrointestinal 2Other 1Gynecologic 1

Conditions

Dysgeusia 2Radiation Injuries 1Mouth Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 416Radiotherapy 240Radiotherapy, Intensity-Modulated 178Cetuximab 177Docetaxel 166pembrolizumab 148Carboplatin 121Fluorouracil 113Paclitaxel 90Nivolumab 82Gemcitabine 82Radiation 72Surveys and Questionnaires 71Drug Therapy 70toripalimab 68Surgical Procedures, Operative 64Magnetic Resonance Spectroscopy 63Capecitabine 50Blood Specimen Collection 50Chemoradiotherapy 46Biopsy 44camrelizumab 41durvalumab 40Radiosurgery 40Standard of Care 38Erlotinib Hydrochloride 34nimotuzumab 32130-nm albumin-bound paclitaxel 32tislelizumab 31apatinib 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Zinc Sulfate × Head & Neck × Clear all
NCT03824925 2019-01-31

Efficacy of Zinc on Concurrent Chemo-radiotherapy Induced Taste Alterations

Dow University of Health Sciences

Phase 3 Completed
70 enrolled
Head & Neck

Dysgeusia, Mouth Neoplasms

NCT00036881 2016-07-14

Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
173 enrolled
Head & Neck

Dysgeusia, Head and Neck Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡